Events

Agenda: Co-creating conceptual, implementable, and transactable solutions and calls to action Webinar #3 will focus on the key areas of convergence, divergence and consensus-building.

Agenda: EMIG Meeting: Pharma and Competition Law: The Big Picture in 2026 The talk will cover: 1. An overview of competition law as it applies to the pharmaceuticals sector. 2. Developments in the law of excessive pricing. 3. The emergence of damages claims by the NHS against pharmaceutical companies. 4. The import of US-style class actions to this jurisdiction.

Agenda: Update on legislation on environmental sustainability

Agenda: Environmental sustainability is a large topic. Many companies have asked: "Do I need to report this, and if I don't, why should I? What is the value to the organisation?" The answer to this question is 'WHY' the Environmental Sustainability and Commercial Strategy Group at EMIG was created. In this session we will cover (guest speaker to be announced): Forthcoming policy changes and what you need to know The pros / cons of reporting; even if not mandatory Establish a core group to create a Policy toolkit to support EMIG members. Open discussion Please register for this highly interactive F2F session that is designed to address one of the more complicated areas impacting all parts of the business.

Agenda: Mismanaged access? Why managed access has stalled as an entry route into the UK market, and what changes are needed to make it work once more Robert Kettell. Discussion on HMG commitments following the Joint Taskforce

Agenda: Our speakers include: How to build and run Advisor Networks digitally. - Ben Blackmore, CEO of BMore Group 5 things AI can do for you today – Gill Adams, Managing Director of LAB (Learner Adams Bones) How digital tools and data can maximise congresses - Nick Beckingham, Managing Partner of Space & Time The Pharma Sales Organisation of the Future - Designed and Powered by AI – Jiten Jain, VP, Docoree

Agenda: IF YOU ARE UNABLE TO REGISTER FOR THE MEETING, THEN PLEASE EMAIL JILL.PAYNE@EMIG.ORG.UK WHO CAN STILL REGISTER YOU.

Agenda: Presentation of findings and final recommendations

Agenda: Our guest speaker is Baronnes Ayesha Hazarika MBE, a Scottish politician, political commentator and former political adviser to senior Labour Party politicians, who we have enjoyed as a previous speaker. Tickets include a drinks reception, followed by a 3 course dinner with wine and cost £350 each or a table of 10 is £2750. Bring colleagues to enjoy this informal networking event.

Agenda: To be announced Meeting sponsored by Macdonald Lewis Associates and Alchemist Consulting

Agenda: Can AI reverse Eroom’s Law? Making the best of AI in biopharma - Speaker Ben Gallarda, IQVIA

Agenda: "What do you need for your career development ?” Navigating the complex territory of training, coaching and mentoring our speaker is Patti Seabright, following her hugely successful session last year

Agenda: The EU Pharma Package - Please join us for a practical, interactive webinar on EU pharmaceutical legislation and its impact on the UK. The speakers will be Wendy Dodd, Associate Director of Regulatory, and Neil Prideaux, Regulatory Manager, at the regulatory, PV and Quality consultancy group, regenold. They will walk you through the key changes arising from the new EU pharmaceutical legislation and what they mean for those operating in the UK market.

Agenda: Terry McErlane will bring us up to date with all of the changes in health in Northern Ireland. Terry is also happy to answer any questions you may have regarding health in Northern Ireland. Please forward any questions to jill.payne@emig.org.uk who will send them to Terry for answering during the online meeting.

Agenda: David Hutchings will give an overview of what work the Value Based Medicines Group do and cover what industry should know about how they work.

Agenda: About the series The need for a multi-stakeholder, whole-system discussion on how the UK can deliver better, less fragmented, and more balanced policies has never been greater. This discussion will be the focus of the webinar series and face-to-face meeting, as part of the relaunched EMIG PO SIG.

Agenda: Terry McErlane will bring us up to date with all of the changes in health in Northern Ireland. Terry is also happy to answer any questions you may have regarding health in Northern Ireland. Please forward any questions to jill.payne@emig.org.uk who will send them to Terry for answering during the online meeting.

Agenda: This meeting is now full. If you wish to attend, please email jill.payne@emig.org.uk who will hold a waiting list on a first come first served basis.

Agenda: Nick Broughton will discuss with David Williams how companies can consider the ethical implications of AI that they introduce so as to mitigate risk and optimise the benefit. I will use AI in medical affairs tasks as an example to highlight the approach. We will look at the characteristics of AI and humans and examine the things to think about in the interaction.

Agenda: Registration for this meeting is still open - if you wish to register please email jill.payne@emig.org.uk Discussion on Sprint 2. Brenda Dooley, will speak on Market Access in Ireland including the new stakeholder agreement between IPHA and Irish State which confirms a commitment to a 180-day reimbursement decidion timeline and Carl Prescott will speak on the NICE consultation on EQ5D-5L.

Agenda: Our speakers are: Rob Kettell, Dave West, Jyotika Singh, Ben Richardson & Helen Knight If you wish to cancel or book for this event, please email jill.payne@emig.org.uk who will help you

Agenda: Discuss current industrial and health strategy issues and challenges to better understand the different perspectives and viewpoints from implicated stakeholders

Agenda: To follow. To register you interest please go to https://www.vwv.co.uk/business/sectors/pharmaceutical-life-sciences-law/ping/ Standard rate - Available from Saturday, 11 April 2026 Full conference including dinner and entertainment: £340 +VAT Day delegate rate (for delegates unable to stay for the evening programme): £210 +VAT

Agenda: Sue Jameson will go through the changes in the PMCPA code amongst other things Social Media, package deals and arms length sponsorship

Agenda: David Williams speaks with Sheuli Porkess and John-Paul Mattar regarding "What is the impact of the real world on pharmaceutical medicine – why what you do matters’